Initial evaluation of 18F-GE-179, a putative PEt tracer for activated N-methyl D-aspartate receptors

Journal of Nuclear Medicine

Volumn 55, Issue 3, 2014, Pages 423-430

  McGinnity, Colm J ^a,b   Hammers, Alexander ^a,e   Barros, Daniela A Riaño ^a,b   Luthra, Sajinder K ^c   Jones, Paul A ^f   Trigg, William ^f   Micallef, Caroline ^d,e   Symms, Mark R ^d,e   Brooks, David J ^a,f   Koepp, Matthias J ^b,d,e   Duncan, John S ^b,d,e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^c CERMEP IMAGERIE DU VIVANT   (France)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e EPILEPSY SOCIETY   (United Kingdom)

^f GE HEALTHCARE   (United Kingdom)

Author keywords

CNS 5161; GE 179; NMDA; PET

Indexed keywords

GE 179; GE 179 F 18; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; GUANIDINE DERIVATIVE; LIGAND; N METHYL DEXTRO ASPARTIC ACID; TRACER;

ADULT; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NEUROIMAGING; NORMAL HUMAN; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RADIATION DOSE DISTRIBUTION; BIOLOGICAL MODEL; BRAIN; CHEMISTRY; CLINICAL TRIAL; CNS 5161; GE-179; KINETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PET; RADIOCHEMISTRY; SCINTISCANNING;

CNS 5161; GE-179; NMDA; PET;

ADULT; BRAIN; FEMALE; GUANIDINES; HUMANS; KINETICS; LIGANDS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RADIOCHEMISTRY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84899479699     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.130641     Document Type: Article

References (40)

1. Furukawa H, Singh SK, Mancusso R, Gouaux E. Subunit arrangement and function in NMDA receptors. Nature. 2005;438:185-192.
2. Sattler R, Xiang ZG, Lu WY, Hafner M, MacDonald JF, Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science. 1999;284:1845-1848.
3. Leker RR, Shohami E, Leker RR, Shohami E. Cerebral ischemia and traumadifferent etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Brain Res Rev. 2002;39:55-73.
4. Kalia LV, Kalia SK, Salter MW, Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol. 2008;7: 742-755.
5. Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci. 2007;8:413-426.
6. Sobrio F, Gilbert G, Perrio C, Barre L, Debruyne D. PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development. Mini Rev Med Chem. 2010;10:870-886.
7. Waterhouse RN. Imaging the PCP site of the NMDA ion channel. Nucl Med Biol. 2003;30:869-878.
8. Asselin MC, Hammers A, Turton D, Osman S, Koepp M, Brooks D. Initial kinetic analyses of the in vivo binding of the putative NMDA receptor ligand [C-11]CNS 5161 in humans. Neuroimage. 2004;22(suppl 2):T137-T138.
9. Hammers A, Asselin MC, Brooks DJ, et al. Correlation of memory function with binding of [C-11]CNS 5161, a novel putative NMDA ion channel PET ligand. Neuroimage. 2004;22(suppl 2):T54-T55.
10. Ahmed I, Bose SK, Pavese N, et al. Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias. Brain. 2011;34:979-986.
11. Robins EG, Zhao Y, Khan I, Wilson A, Luthra SK, Arstad E. Synthesis and in vitro evaluation of 18F-labelled S-fluoroalkyl diarylguanidines: novel high-affinity NMDA receptor antagonists for imaging with PET. Bioorg Med Chem Lett. 2010;20:1749-1751.
12. Hu LY, Guo J, Magar SS, Fischer JB, Burke-Howie KJ, Durant GJ. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N9-(3-substituted phenyl)- N9-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers. J Med Chem. 1997;40:4281-4289.
13. Biegon A, Gibbs A, Alvarado M, et al. In vitro and in vivo characterization of [3H]CNS-5161-a use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain. Synapse. 2007;61:577-586.
14. Defrise M, Kinahan PE, Townsend DW, Michel C, Sibomana M, Newport DF. Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans Med Imaging. 1997;16:145-158.
15. Hammers A, Asselin MC, Turkheimer FE, et al. Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [11C] diprenorphine test-retest data. Neuroimage. 2007;38:82-94.
16. Turkheimer FE, Brett M, Visvikis D, Cunningham V. Multiresolution analysis of emission tomography images in the wavelet domain. J Cereb Blood Flow Metab. 1999;19:1189-1208.
17. Seventh annual meeting of the Organization for Human Brain Mapping: June 10-14, 2001, Brighton, United Kingdom. NeuroImage. 2001;13(6, suppl):1-1341.
18. Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26:839-851.
19. Hammers A, Allom R, Koepp MJ, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp. 2003;19:224-247.
20. Heckemann RA, Keihaninejad S, Aljabar P, et al. Automatic morphometry in Alzheimer's disease and mild cognitive impairment. Neuroimage. 2011;56: 2024-2037.
21. Paoletti P, Neyton J, Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol. 2007;7:39-47.
22. Turkheimer FE, Hinz R, Gunn RN, Aston JA, Gunn SR, Cunningham VJ. Rankshaping regularization of exponential spectral analysis for application to functional parametric mapping. Phys Med Biol. 2003;48:3819-3841.
23. Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab. 1993;13:15-23.
24. Ametamey SM, Bruehlmeier M, Kneifel S, et al. PET studies of 18F-memantine in healthy volunteers. Nucl Med Biol. 2002;29:227-231.
25. Matsumoto R, Haradahira T, Ito H, et al. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c]methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography. Synapse. 2007;61:795-800.
26. Hartvig P, Valtysson J, Lindner KJ, et al. Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers. Clin Pharmacol Ther. 1995;58:165-173.
27. Kumlien E, Hartvig P, Valind S, Oye I, Tedroff J, Langstrom B. NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia. 1999;40:30-37.
28. Owens J, Wyper DJ, Patterson J, et al. First SPET images of glutamate (NMDA) receptor activation in vivo in cerebral ischaemia. Nucl Med Commun. 1997;18:149-158.
29. Erlandsson K, Bressan RA, Mulligan RS, et al. Kinetic modelling of [123I]CNS 1261: a potential SPET tracer for the NMDA receptor. Nucl Med Biol. 2003;30: 441-454.
30. Brown DR, Wyper DJ, Owens J, et al. 123Iodo-MK-801: a SPECT agent for imaging the pattern and extent of glutamate (NMDA) receptor activation in Alzheimer's disease. J Psychiatr Res. 1997;31:605-619.
31. Monaghan DT, Cotman CW. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci. 1985;5:2909-2919.
32. Stys PK, Lipton SA. White matter NMDA receptors: an unexpected new therapeutic target? Trends Pharmacol Sci. 2007;28:561-566.
33. Scherzer CR, Landwehrmeyer GB, Kerner JA, et al. Cellular distribution of NMDA glutamate receptor subunit mRNAs in the human cerebellum. Neurobiol Dis. 1997;4:35-46.
34. Erreger K, Dravid SM, Banke TG, Wyllie DJ, Traynelis SF. Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Physiol. 2005;563:345-358.
35. Dravid SM, Prakash A, Traynelis SF. Activation of recombinant NR1/NR2C NMDA receptors. J Physiol. 2008;586:4425-4439.
36. Wyllie DJ, Behe P, Colquhoun D. Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors. J Physiol. 1998;510:1-18.
37. Rigby M, Le Bourdelles B, Heavens RP, et al. The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience. 1996;73:429-447.
38. Forst T, Smith T, Schutte K, Marcus P, Pfutzner A, CNS Study Group. Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain. Br J Clin Pharmacol. 2007;64:75-82.
39. Buijs PC, Krabbe-Hartkamp MJ, Bakker CJ, et al. Effect of age on cerebral blood flow: measurement with ungated two-dimensional phase-contrast MR angiography in 250 adults. Radiology. 1998;209:667-674.
40. Foster TC. Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-D-aspartate receptors and voltage-dependent Ca21 channels in senescent synaptic plasticity. Prog Neurobiol. 2012;96:283-303.